Baxter International Inc.BAXNYSE
Loading

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
22 analysts·High coverage
36%
Rating Distribution
Strong Buy
00%
Buy
836%
Hold
1359%
Sell
15%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Price is near analyst consensus — limited near-term upside expected.

Bear Case
$15.00
-21%
Consensus
$19.75
+4%
Bull Case
$25.00
+31%
Price Range22 analysts
Low
Consensus
High
$15.00
$25.00
Current Target
Current Price
$19.03
Upside to Target
$0.72

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$1.93(9 analysts)
Actual
Estimate
Range (Low–High)
Stock Alarm Pro
Forward Growth Estimates (YoY)
FY2027
Rev+2.41%
EPS+5.65%
FY2028
Rev+2.80%
EPS+17.80%

Earnings Surprises

Beat rate:75%(9/12 quarters)
Avg surprise:+4.5%
Beat
Miss
Inline
Estimate
Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Feb 17, 2026Goldman Sachs
Baxter price target lowered to $17 from $21 at Goldman Sachs
Target:$17.00
-17.2%from $20.54
Feb 16, 2026UBS
Baxter price target lowered to $19 from $21 at UBS
Target:$19.00
-4.0%from $19.79
Feb 13, 2026Deutsche Bank
Baxter price target lowered to $20 from $22 at Deutsche Bank
Target:$20.00
+4.0%from $19.23
Feb 13, 2026Barclays
Baxter price target lowered to $25 from $30 at Barclays
Target:$25.00
+33.6%from $18.71
Feb 12, 2026Jefferies
Baxter price target lowered to $19 from $21 at Jefferies
Target:$19.00
+1.5%from $18.71
Feb 12, 2026Stifel Nicolaus
Baxter price target lowered to $20 from $22 at Stifel
Target:$20.00
+6.9%from $18.71
Jan 9, 2026Barclays
Baxter price target lowered to $30 from $36 at Barclays
Target:$30.00
+45.0%from $20.69
Jan 9, 2026Goldman Sachs
Baxter price target raised to $23 from $22 at Goldman Sachs
Target:$23.00
+11.2%from $20.69
Jan 5, 2026Evercore ISI
Baxter price target lowered to $23 from $24 at Evercore ISI
Target:$23.00
+14.9%from $20.02
Dec 2, 2025Morgan Stanley
Baxter price target lowered to $15 from $19 at Morgan Stanley
Target:$15.00
-21.4%from $19.08
Oct 31, 2025Goldman Sachs
Baxter price target lowered to $22 from $25 at Goldman Sachs
Target:$22.00
+17.0%from $18.81
Oct 30, 2025Stifel Nicolaus
Baxter price target lowered to $22 from $25 at Stifel
Target:$22.00
+14.7%from $19.18
Aug 4, 2025Barclays
Barclays cuts Baxter target, says selloff 'significantly overdone'
Target:$36.00
+60.4%from $22.44
Aug 4, 2025UBS
Baxter price target lowered to $24 from $35 at UBS
Target:$24.00
+7.0%from $22.44
Jan 2, 2025Evercore ISI
Baxter price target lowered to $42 from $45 at Evercore ISI
Target:$42.00
+43.5%from $29.26
Oct 4, 2024Bank of America Securities
BofA Securities Reiterates Neutral Rating on Baxter International (BAX)
Target:$45.00
+23.9%from $36.32
Aug 6, 2024Jefferies
Baxter International (BAX) PT Lowered to $42 at Jefferies
Target:$42.00
+13.8%from $36.92
Jul 15, 2024Morgan Stanley
Baxter downgraded to Underweight from Equal Weight at Morgan Stanley
Target:$30.00
-15.1%from $35.32
Jun 12, 2024Goldman Sachs
Goldman Sachs Reiterates Neutral Rating on Baxter International (BAX)
Target:$36.00
+8.1%from $33.31
May 3, 2024UBS
Baxter International (BAX) PT Lowered to $40 at UBS
Target:$40.00
+8.4%from $36.91
May 2, 2024Jefferies
Baxter International (BAX) PT Lowered to $43 at Jefferies
Target:$43.00
+16.6%from $36.89
May 2, 2024Stifel Nicolaus
Baxter price target lowered to $44 from $50 at Stifel
Target:$44.00
+19.8%from $36.73
Jul 31, 2023Barclays
Software Update Leads To False Alarms In Baxter's Spectrum Infusion Pumps, Urgent Correction Underway
Target:$54.00
+19.3%from $45.26
Jul 31, 2023Jefferies
Apple To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Monday
Target:$85.00
+80.8%from $47.01
Mar 27, 2023Citigroup
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
Target:$44.00
+10.8%from $39.71